This class of mutation causes abnormal post‐translational processing of the CFTR protein, which prevents the protein from trafficking to the correct cellular location, as exemplified by the F508del mutation that is present in a homozygous state in approximately 50% of CF patients and in at least a heterozygous state in 90% of CF patients.10 Here, CFTR is linked to cystic fibrosis.